Synthesis and Labeling of Two Fibrin-Targeted Peptides (HYNICGPRPILE, HYNIC-GPKGAAD) Using Technetium-99m and In Vitro Evaluation of Fibrin Binding and Platelet Aggregation Fibrin-targeted peptides for molecular imaging of thrombus
Trends in Peptide and Protein Sciences,
Vol. 6 (2021),
24 February 2021
,
Page 1-6 (e3)
https://doi.org/10.22037/tpps.v6i.35296
Abstract
Early detection of thrombus and its location in the body are critical factors for the treatment of thrombosis related diseases. Fibrin is the main component of thrombus, abundant in all thrombi, and is not found in non-pathological conditions. The presence of fibrin in all types of thrombi and its low concentration in blood makes it a sensitive and specific target for imaging studies of thrombus. Fibrin also accumulates in malignant tumors. Thus, fibrin imaging can be used in oncology, atherosclerosis, and thrombosis-related pathologies such as pulmonary emboli and deep vein thrombosis. Different compounds such as antibodies, nanoparticles, and peptides have been studied for fibrin imaging. Among them, peptides are more attractive because of better pharmacokinetics, simple and cheap preparation, and better radiolabeling methods. In this study, two peptides (HYNIC-GPRPILE, HYNIC-GPKGAAD) designed to target fibrin were synthesized. The peptides were identified by LC-MS. The stability and platelet aggregation of peptides were determined. Peptides were radiolabeled with 99mTc using HYNIC as chelating agent. The release of 99mTc and fibrin binding of radiopeptides were evaluated. Based on the results, peptides were stable in human plasma for at least 6 h and had no effect on platelet aggregation. Peptides were radiolabeled with pertechnetate at 80°C in 30 min. Radiochemical purity was over 95%. Radiopeptides were stable in human plasma and there was less than 5% release of 99mTc. The fibrin binding of radiopeptides was 70%>. Since peptides had no platelet binding activity, it can be concluded that binding of radiopeptides to fibrin is specific.
HIGHLIGHTS
- Molecular imaging of fibrin used in oncology, atherosclerosis, and thrombosis related pathologies.
- Invasive early detection of thrombus using radiolabeled fibrin targeted peptides.
- Radiolabeling of peptides with 99mTc using HYNIC as chelating agent and EDDA and tricine as co-ligand.
- Thrombus
- 99mTc
- Fibrin
- HYNIC
- Peptide
How to Cite
References
Amidi, S., Kobarfard, F., Moghaddam, A.B., Tabib, K. and Z. Soleymani, (2013). ʺElectrochemical synthesis of novel 1, 3-indandione derivatives and evaluation of their antiplatelet aggregation activities.ʺ Iranian Journal of Pharmaceutical Research: IJPR, 12(Suppl): 91-103.
Aruva, M.R., Daviau, J., Sharma, S.S. and M.L. Thakur, (2006). ʺImaging thromboembolism with fibrin-avid 99mTc-peptide: evaluation in swine.ʺ Journal of Nuclear Medicine, 47(1): 155-162.
Chung, E.J., Cheng, Y., Morshed, R., Nord, K., Han, Y., Wegscheid, M.L., Auffinger, B., Wainwright, D.A., Lesniak, M.S. and M.V. Tirrell, (2014). ʺFibrin-binding, peptide amphiphile micelles for targeting glioblastoma.ʺ Biomaterials, 35(4): 1249-1256.
Ciesienski, K.L., Yang, Y., Ay, I., Chonde, D.B., Loving, G.S., Rietz, T.A., Catana, C. and P. Caravan, (2013). ʺFibrin-targeted PET probes for the detection of thrombi.ʺ Molecular Pharmaceutics, 10(3): 1100-1110.
Fang, W., He, J., Kim, Y.S., Zhou, Y. and S. Liu, (2011). ʺEvaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.ʺ Bioconjugate Chemistry, 22(8): 1715-1722.
Hara, T., Bhayana, B., Thompson, B., Kessinger, C.W., Khatri, A., McCarthy, J.R., Weissleder, R., Lin, C.P., Tearney, G.J. and F.A. Jaffer, (2012). ʺMolecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.ʺ JACC: Cardiovascular Imaging, 5(6): 607-615.
Knight, L.C. (2001). ʺRadiolabeled peptide ligands for imaging thrombi and emboli.ʺ Nuclear Medicine and Biology, 28(5): 515–526.
Kongsuphol, P., Arya, S.K., Wong, C.C., Polla, L.J. and M.K. Park, (2014). ʺCoiled-coil peptide based sensor for ultra-sensitive thrombin detection.ʺ Biosensors and Bioelectronics, 55: 26-31.
Mosayebnia, M., Hajiramezanali, M., Shahhosseini, S., Bozorgi, A.H., Kobarfard, F. and S.Rezaeianpour, (2018). ʺDocking, synthesis, in-vitro evaluation, and optimization of reaction conditions for direct radiolabeling of CGPRPPC with technetium-99m through the GAGG sequence.ʺ Nuclear Medicine Communications, 39(11): 976-982.
Rezaeianpour, S., Bozorgi, A.H., Moghimi, A., Almasi, A., Balalaie, S., Ramezanpour, S., Nasoohi, S., Mazidi, S.M., Geramifar, P., Bitarafan-Rajabi, A. and S. Shahhosseini, (2017). ʺSynthesis and biological evaluation of cyclic [99m Tc]-hynic-cgprppc as a fibrin-binding peptide for molecular imaging of thrombosis and its comparison with [99m Tc]-HYNIC-GPRPP.ʺ Molecular Imaging and Biology, 19(2): 256-264.
Rezaeianpour, S., Mosayebnia, M., Moghimi, A., Amidi, S., Geramifar, P., Kobarfard, F. and S. Shahhosseini, (2018). ʺ[18F] FDG-labeled CGPRPPC peptide serving as a small thrombotic lesions probe, including a comparison with [99mTc]-labeled form.ʺ Cancer Biotherapy & Radiopharmaceuticals, 33(10): 438-444.
Rosebrough, S.F., McAfee, J.G., Grossman, Z.D. and L.A. Schemancik, (1989). ʺImmunoreactivity of 111In and 131I fibrin-specific monoclonal antibody used for thrombus imaging.ʺ Journal of Immunological Methods, 116(1): 123-129.
Schibli, R. and A.P. Schubiger, (2002). ʺCurrent use and future potential of organometallic radiopharmaceuticals.ʺ European Journal of Nuclear Medicine and Molecular Imaging, 29(11): 1529-1542.
Starmans, L.W., van Duijnhoven, S.M., Rossin, R., Berben, M., Aime, S., Daemen, M.J., Nicolay, K. and H. Grüll, (2013a). ʺEvaluation of 111In-labeled EPep and FibPep as tracers for fibrin SPECT imaging.ʺ Molecular Pharmaceutics, 10(11): 4309-4321.
Starmans, L.W., van Duijnhoven, S.M., Rossin, R., Aime, S., Daemen, M.J., Nicolay, K. and H. Grüll, (2013b). ʺSPECT imaging of fibrin using fibrin‐binding peptides.ʺ Contrast Media & Molecular Imaging, 8(3): 229-237.
Starmans, L.W., van Mourik, T., Rossin, R., Verel, I., Nicolay, K. and H. Grüll, (2015). ʺNoninvasive visualization of tumoral fibrin deposition using a peptidic fibrin-binding single photon emission computed tomography tracer.ʺ Molecular Pharmaceutics, 12(6): 1921-1928.
Thakur, M.L., Pallela, V.R., Consigny, P.M., Rao, P.S., Vessileva-Belnikolovska, D. and R. Shi, (2000). ʺImaging vascular thrombosis with 99mTc-labeled fibrin α-chain peptide.ʺ Journal of Nuclear Medicine, 41(1): 161-168.
- Abstract Viewed: 215 times
- PDF Downloaded: 156 times